Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioCorRx (BICX) Non Operating Income (2016 - 2025)

BioCorRx (BICX) has disclosed Non Operating Income for 11 consecutive years, with $62967.0 as the latest value for Q4 2025.

  • Quarterly Non Operating Income rose 161.2% to $62967.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Dec 2025, up 1372.13% year-over-year, with the annual reading at $1.3 million for FY2025, 1576.48% up from the prior year.
  • Non Operating Income hit $62967.0 in Q4 2025 for BioCorRx, down from $954000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $954000.0 in Q3 2025 to a low of -$268771.0 in Q1 2024.
  • Historically, Non Operating Income has averaged $84406.7 across 5 years, with a median of $54348.0 in 2023.
  • Biggest five-year swings in Non Operating Income: surged 3807.1% in 2022 and later crashed 741.06% in 2023.
  • Year by year, Non Operating Income stood at $131403.0 in 2021, then plummeted by 82.63% to $22821.0 in 2022, then plummeted by 741.06% to -$146297.0 in 2023, then grew by 29.67% to -$102893.0 in 2024, then surged by 161.2% to $62967.0 in 2025.
  • Business Quant data shows Non Operating Income for BICX at $62967.0 in Q4 2025, $954000.0 in Q3 2025, and $36644.0 in Q2 2025.